Integrating Tobacco Use Cessation Into HIV Care and Treatment in Kisumu County, Kenya
Status:
Not yet recruiting
Trial end date:
2026-08-31
Target enrollment:
Participant gender:
Summary
People living with HIV (PLHIV) have higher rates of tobacco use than the general population
and higher rates of disease and death compared with PLHIV who do not use tobacco. This
project will evaluate the impact of integrating an intensive tobacco use cessation
intervention compared to a brief intervention within HIV care clinics in Kisumu County,
Kenya.
There is evidence that PLHIV in Africa are more likely to use tobacco than the general
population. Kenya is an example of a country coping with the dual epidemic of HIV and
tobacco, with an estimated 1.5 million PLHIV and 2.5 million tobacco users. HIV remains one
of the country's leading causes of morbidity and mortality, with an estimated 46,000 adults
acquired HIV and 25,000 persons died of HIV in 2018. Tobacco use among the general population
is estimated to be 11.6% (19.1% among men and 4.5% among women). The impact of tobacco use
among PLHIV in Kenya has yet to be fully understood. There has been no research or
initiatives in Kenya to support PLHIV to quit tobacco use in a primary care setting, a gap
that this study seeks to address. In 2017, Kenya's Ministry of Health launched the National
Guidelines for Tobacco Dependence Treatment and Cessation. This project will also examine the
integration of the Guidelines' interventions into Ministry of Health HIV care clinics in
Kisumu County.
Phase:
Phase 4
Details
Lead Sponsor:
University of California, San Francisco
Collaborators:
Kenya Medical Research Institute National Cancer Institute (NCI)